The research team set out to characterize obesity within pediatric sleep medicine evaluations using a multicenter, real-world design, drawing on clinical data from three geographically and demographically distinct institutions: Rady Children’s Health in San Diego, Vanderbilt Children’s Hospital in Nashville, and Seattle Children’s Hospital. Rather than relying on the highly selected populations that populate randomized trials, the investigators analyzed children who were actually referred for sleep medicine care, a population that reflects the day-to-day reality of pediatric sleep clinics in the United States. The study received institutional review board exemption at all three participating centers, and the analysis was led by Landeo-Gutierrez and Maida Lynn Chen, with conceptualization and manuscript preparation contributions from Rakesh Bhattacharjee, Julie Ryu, Mariana Bedoya, and Erin MacKintosh.

The clinical stakes of this work are considerable. Obesity among children and adolescents in the United States has reached a prevalence that leading pediatric organizations now describe as a public health emergency, a framing advanced in a 2023 Pediatrics commentary by Emily Bomberg, Trina Kyle, and Fatima Cody Stanford. Against that backdrop, sleep disorders and obesity are not merely co-occurring conditions that happen to arrive in the same clinic; they are physiologically intertwined in ways that make each harder to treat in isolation. Understanding how frequently obesity appears among children evaluated in sleep clinics, and in what contexts, is therefore a question with direct implications for how pediatric sleep programs are staffed, how referrals are triaged, and how treatment plans are constructed.

The most extensively documented link between obesity and pediatric sleep pathology is obstructive sleep apnea, the condition in which the upper airway repeatedly narrows or collapses during sleep, interrupting breathing and fragmenting sleep architecture. In children with obesity, excess adipose tissue around the neck, tongue, and abdominal cavity increases mechanical load on the airway and reduces lung volumes, particularly in the supine position during rapid eye movement sleep, when muscle tone naturally falls. Adenotonsillar hypertrophy remains the classic driver of pediatric sleep apnea, but the obesity epidemic has shifted the epidemiology: an increasing proportion of children referred for snoring and suspected sleep-disordered breathing carry excess weight, and obesity-associated sleep apnea tends to be more persistent and less likely to resolve completely after tonsillectomy and adenoidectomy than the disease seen in lean children.

The relationship also runs in the opposite direction, a bidirectionality that has been established through large prospective studies. Systematic reviews and meta-analyses, including a 2018 synthesis by Maria del Carmen Miller, Francesco Cappuccio, and colleagues in the journal Sleep, and an updated dose-response meta-analysis by Xiaoli Deng and colleagues in Sleep Medicine in 2021, have consistently shown that short sleep duration in infants, children, and adolescents predicts subsequent weight gain and incident obesity. The proposed mechanisms are metabolic and behavioral at once: sleep restriction dysregulates the hormones leptin and ghrelin that govern appetite and satiety, increases insulin resistance, extends the waking window during which calories are consumed, and promotes fatigue that displaces physical activity. Cappuccio’s earlier 2008 meta-analysis in Sleep reached the same conclusion across both children and adults, cementing short sleep as a recognized modifiable risk factor for obesity.

Beyond apnea and sleep duration, obesity shapes nearly every other complaint that brings a child to a sleep clinic. A 2022 study by Kelly Duraccio, Dean Beebe, and colleagues in the Journal of Clinical Sleep Medicine examined clinically referred pediatric samples and found meaningful relationships between overweight and obesity status and insomnia severity, sleep quality, and the degree to which insomnia improved with treatment. Children with obesity also show poorer circadian health overall: a 2024 study in World Journal of Pediatrics by María Rodríguez-Martín, Nuria Martínez-Lozano, and colleagues applied a global circadian health score and found that children with obesity fared worse across multiple circadian dimensions, including sleep timing, meal timing, and light exposure patterns. These findings collectively suggest that obesity is not a single comorbidity to be noted in passing but a thread running through the entire fabric of pediatric sleep pathology.

Professional guidelines have begun to reflect this reality. The 2023 American Academy of Pediatrics clinical practice guideline for the evaluation and treatment of children and adolescents with obesity, authored by Sarah Hampl, Sandra Hassink, and an expert panel, recommends intensive health behavior and lifestyle treatment as the foundation of care, with pharmacotherapy and metabolic and bariatric surgery now endorsed as options for appropriate candidates. In adult sleep medicine, the American Thoracic Society’s 2018 clinical practice guideline on weight management for obstructive sleep apnea, led by David Hudgel and Sanjay Patel, formally established weight loss as a component of apnea treatment. Pediatric sleep medicine has been moving in the same direction, but the new multicenter analysis underscores how much of that work now happens, implicitly or explicitly, inside sleep clinics themselves.

Pharmacology is also changing the calculus. The 2024 SURMOUNT-OSA trial, published in the New England Journal of Medicine by Atul Malhotra, Ronald Grunstein, Ingo Fietze, and colleagues, demonstrated that tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, significantly reduced the apnea-hypopnea index in adults with obstructive sleep apnea and obesity, with effects evident both among users and non-users of positive airway pressure therapy. The result electrified the sleep medicine community because it suggested that treating the metabolic disease could directly treat the sleep disorder. Whether incretin-based therapies will prove safe and effective for adolescents with obesity-associated sleep apnea remains an open question, but the adult evidence has already intensified interest in accurate weight characterization at the moment of pediatric sleep referral, precisely the kind of real-world data the new research letter provides.

The multicenter design of the study matters for how its insights should be read. Single-center pediatric sleep cohorts are inevitably shaped by local referral patterns, regional demographics, and institutional practice, so findings from three large programs in San Diego, Nashville, and Seattle carry more weight as a description of the national picture. The authors report that the data informing their figures and tables are available upon reasonable request, and the study was supported in part by a Robert A. Winn Excellence in Clinical Trials Career Development Award to the lead author and a Health Resources and Services Administration training grant supporting the Seattle team. The research letter format means the analysis is deliberately concise, but its framing points toward a larger conclusion: pediatric sleep medicine can no longer be practiced without embedded weight-related assessment and, ideally, integrated weight management pathways.

For clinicians and families, the practical message is one of shared vigilance. A child referred for snoring should have height, weight, and body mass index documented and interpreted against growth curves, because the presence of obesity changes the probability of sleep apnea, the likelihood of surgical cure, and the range of treatment options worth discussing. Conversely, a child being evaluated for obesity should be screened for snoring, witnessed apneas, daytime sleepiness, and sleep duration, because untreated sleep disorder can undermine even the most carefully constructed weight management plan. As the obesity epidemic continues to reshape pediatric medicine, studies like this one, grounded in the unselected reality of clinic populations rather than trial cohorts, provide the evidence base for that integration. The three-center collaboration behind the new analysis signals a growing recognition that the future of pediatric sleep medicine and the future of pediatric obesity care are, in a very literal sense, the same future.

Subject of Research: The prevalence and clinical implications of obesity among children evaluated in pediatric sleep medicine clinics

Article Title: Obesity in pediatric sleep medicine evaluations: insights from a real-world multicenter analysis

Article References: Obesity in pediatric sleep medicine evaluations: insights from a real-world multicenter analysis. (n.d.). https://doi.org/10.1007/s44470-026-00138-z

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00138-z

Keywords: pediatric sleep medicine, obesity, obstructive sleep apnea, children, sleep duration, insomnia, circadian health, tirzepatide, adenotonsillectomy, weight management, multicenter study, Journal of Clinical Sleep Medicine